Status:
COMPLETED
Methods Project 4: Clinical Trial
Lead Sponsor:
University of Minnesota
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Smoker
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Cigarette smokers who are eligible will enter a Camel Snus sampling phase. Smokers interested in continuing with the study after the sampling phase will undergo a 2 week baseline assessment phase and ...
Detailed Description
Baseline smoking period: Subjects will be required to attend 2 baseline clinic visits where baseline assessments will be captured including a record of their cigarette or other tobacco intake on a dai...
Eligibility Criteria
Inclusion
- Male or female subjects who are at least 18 years of age;
- Daily smoker;
- Generally good health;
- Subject has provided written informed consent to participate in the study (adolescents under the age of 18 will be excluded because this project involves continued use of tobacco products and new tobacco products);
Exclusion
- Unstable health
- Pregnant or breastfeeding (due to toxic effects from tobacco products).
- Unable to read for comprehension or completion of study documents.
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2018
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT01867242
Start Date
July 1 2013
End Date
May 1 2018
Last Update
May 3 2023
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Masonic Cancer Center, University of Minnesota
Minneapolis, Minnesota, United States, 55455
2
Roswell Park Cancer Center
Buffalo, New York, United States, 14263
3
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States, 43210